The telecom industry is divided over the Centre's decision to delicense the lower 6 GHz band for Wi-Fi. Reliance Jio supports ...

The adaptive, biomarker-directed trial allows researchers to enrich for best responders and open new sub-studies for non-responders based on emerging data.